Development of glycopolymers for the therapy of viral infections - Textes

Accueil
Navigation principale
Contenu
Recherche
Aide

Fonte Standard Gras
Identifiant

Unité de recherche

INNOSUISSE

Numéro de projet

102.884.1 IP-LS

Titre du projet

Development of glycopolymers for the therapy of viral infections

Titre du projet anglais

Development of glycopolymers for the therapy of viral infections

Textes relatifs à ce projet

	Allemand	Français	Italien	Anglais
Description succincte		-	-
Résumé des résultats (Abstract)		-	-

Textes saisis

Catégorie	Texte
Description succincte (Allemand)	Development of glycopolymers for the therapy of viral infections
Description succincte (Anglais)	Development of glycopolymers for the therapy of viral infections
Résumé des résultats (Abstract) (Allemand)	In response to the COVID-19 pandemic we developed a novel therapeutic approach to tackle viral infections. We demonstrated that our glycopolymers successfully inhibit viral protein attachment of a variety of unrelated viral pathogens and more specifically inhibit infection of SARS-CoV-2 in vitro.
Résumé des résultats (Abstract) (Anglais)	In response to the COVID-19 pandemic we developed a novel therapeutic approach to tackle viral infections. We demonstrated that our glycopolymers successfully inhibit viral protein attachment of a variety of unrelated viral pathogens and more specifically inhibit infection of SARS-CoV-2 in vitro.